Concepedia

Michael Mortimore

MM

13

Publications

1.1K

Citations

13

H-Index

1987

Active since

Affiliations

The University of Texas at Austin(Current)

Vertex Pharmaceuticals (United Kingdom)

Loughborough University

University of Southampton

AstraZeneca (United Kingdom)

Michael Mortimore is an author at The University of Texas at Austin specializing in pharmacology, natural sciences, and medicine.

Top concepts

Publications per year

1987–2013

13

Publications

13

Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents

Jean‐Damien Charrier, Steven J. Durrant, Julian M.C. Golec et al. · Journal of Medicinal Chemistry · 2011 · 256 citations · Full text

, , +19

Biogenetically Inspired Approach to the <i>Strychnos </i>Alkaloids. Concise Syntheses of (±)-Akuammicine and (±)-Strychnine

Masayuki Ito, Cameron W. Clark, Michael Mortimore et al. · Journal of the American Chemical Society · 2001 · 159 citations

Characterization of a selective and potent antagonist of human P2X<sub>7</sub>receptors, AZ11645373

Leanne Stokes, Lin‐Hua Jiang, Lindsay B. Alcaraz et al. · British Journal of Pharmacology · 2006 · 130 citations · Full text

The discovery of the potent aurora inhibitor MK-0457 (VX-680)

David Bebbington, Hayley Binch, Jean‐Damien Charrier et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 99 citations · Full text

, , +8

Unified strategy for synthesis of indole and 2-oxindole alkaloids

Stephen F. Martin, J. E. Hunter, B. BENAGE et al. · Journal of the American Chemical Society · 1991 · 87 citations

, , +9

Rows per page

1–5 of 13